Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Apricus Bio Moves Forward With Viagra Competitor Vitaros
Seeking Alpha
Wednesday, June 15, 2011 - 12:45pm
tags:
erectile dysfunction, Viagra, Vitaros, Apricus Biosciences
Regeneron Eye Drug to Rival Lucentis Works in U.S. Review
Bloomberg
Wednesday, June 15, 2011 - 10:01am
tags:
Lucentis, Regeneron, Roche, VEGF Trap-Eye
J&J to Cut 900-1,000 Jobs, Take $500 Mln-$600 Mln Charge
Bloomberg
Wednesday, June 15, 2011 - 9:31am
tags:
JNJ, layoffs, restructuring, Cordis
Pharma Complexity Is Leading to Loss of Profits
PharmExec
Wednesday, June 15, 2011 - 9:03am
tags:
profits, Novartis, JNJ, Pfizer, Bayer, Roche, complexity
Can Biocon get a $1B pharma deal for its oral insulin program?
Fierce Biotech
Wednesday, June 15, 2011 - 9:01am
tags:
insulin, diabetes, Biocon, India, Sanofi, Bristol-Myers Squibb
Sanofi putting stamp on Genzyme
Boston.com
Wednesday, June 15, 2011 - 8:47am
tags:
Genzyme, Sanofi, M&A
Aveo Pharma starts offering of stock, but does not disclose how many shares it is selling
Yahoo/AP
Wednesday, June 15, 2011 - 8:32am
tags:
Aveo Pharmaceutical, stock offering
Merck With AstraZeneca Leads Rivals-Turned-Allies in Cancer
Bloomberg
Wednesday, June 15, 2011 - 8:31am
tags:
Merck, AstraZeneca, cancer
Adolor to buy out GSK stake in Entereg
Bizjournals.com
Wednesday, June 15, 2011 - 8:29am
tags:
GSK, Entereg, Adolor
3 Ways to Play Biotech With Options
Motley Fool
Tuesday, June 14, 2011 - 8:05pm
tags:
Amarin, SIGA technologies, Acorda Therapeutics, Orexigen, Vivus
Boehringer, Pfizer’s Spiriva May Raise Death Risk, Study Finds
Bloomberg
Tuesday, June 14, 2011 - 8:04pm
tags:
Pfizer, Boehringer Ingelheim, Spiriva, COPD
Abbott Overturning of $1.67 Billion J&J Patent Verdict to Stand
Bloomberg
Tuesday, June 14, 2011 - 8:03pm
tags:
Abbott Laboratories, JNJ, patents, Humira
GSK dealmaking: OTC buyers, China buyouts
Fierce Pharma
Tuesday, June 14, 2011 - 1:16pm
tags:
OTC, China, GSK, M&A
CMS Decision Due on Provenge
Yahoo/Zacks.com
Tuesday, June 14, 2011 - 1:14pm
tags:
Provenge, Dendreon, prostate cancer, Medicare, Medicaid, CMS
Cell Therapeutics meets with FDA
Bizjournals.com
Tuesday, June 14, 2011 - 10:15am
tags:
FDA, Cell Therapeutics
Scientists warn on "dead space" as pharma giants shun neuropsych
Fierce Biotech
Tuesday, June 14, 2011 - 9:25am
tags:
R&D, neuropsychology, GSK, AstraZeneca
Actavis Seeks Emerging-Market Partner to Copy Roche Cancer Drugs
Bloomberg
Tuesday, June 14, 2011 - 9:18am
tags:
Actavis, Roche, emerging markets, biosimilars
New lupus drug, Benlysta, gets only mixed reactions from patients, experts
Washington Post, DC
Tuesday, June 14, 2011 - 9:15am
tags:
lupus, Human Genome Sciences, Benlysta, GSK
Bristol-Myers Squibb, Sanofi-Aventis in race for drug marketing pact with Biocon
Economic Times, India
Tuesday, June 14, 2011 - 9:13am
tags:
Bristol-Myers Squibb, Sanofi, India, Biocon
CytRx: Small Oncology Firm Offers Unique Exposure to Big Pharma Culture
Seeking Alpha
Tuesday, June 14, 2011 - 9:11am
tags:
CytRx, oncology, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.